Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

FDA has Xarelto concerns

July 2, 2013 Sales and Marketing Bayer, Boehringer, FDA, Pradaxa, Xarelto

The FDA is unsure about an application to further extend the licence for Janssen and Bayer HealthCare’s blood thinner Xarelto …
News

Remicade copies set for European entry

July 1, 2013 Sales and Marketing CHMP, Hospira, Janssen, Remicade, arthritis, biosimilar

Janssen’s Remicade could soon come under generic pressure after a landmark recommendation by the CHMP. South Korean biotech Celltrion and …
News

Ben Adams appointed editor of Pharmafocus

July 1, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Adams, McConaghie, Pharmafocus

Ben Adams has become the new editor of the monthly Pharmafocus newspaper and the Pharmafile.com website. Adams, formerly the senior …
Appointment

Sanofi’s Lemtrada nears EU approval

July 1, 2013 Sales and Marketing CHMP, Genzyme, Lemtrada, Sanofi

Sanofi’s multiple sclerosis drug Lemtrada has received a positive recommendation from the CHMP, meaning a European approval is likely just …
News

A call for harmony on clinical trials

July 1, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Frédéric Sgard, OECD, clinical trials

Clinical trials are an essential part of the development of medical treatments. They involve testing new medicines or new therapies, …
Feature

Lords: ‘Simplify pharma regulation’

July 1, 2013 Sales and Marketing Lords, NICE, pharma, regulation

Investors are not putting their money into the UK’s regenerative medicine sector because of the high failure rate when it …
News

‘Three-person’ IVF consultation

June 28, 2013 Research and Development, Sales and Marketing DoH, HFEA, IVF

The Department of Health is to publish draft guidelines later this year on a controversial IVF-based technique which would lead …
News

Survey: ‘Consultants prefer mailshots’

June 28, 2013 Medical Communications, Sales and Marketing Onyx, digital, mailshots

Pharma should use standard marketing activities such as mailshots if they want to promote their products effectively in UK secondary …
News

Diabetes vaccine trial posts positive results

June 28, 2013 Research and Development, Sales and Marketing TOL-3021, Vaccine, diabetes

A groundbreaking new study suggests that the body’s immune system can be taught to reverse the effects of type 1 …
News

Life appoints new account manager

June 28, 2013 Medical Communications, Research and Development, Sales and Marketing Life, mead

Creative comms agency Life has expanded its client service team with the appointment of a new account manager.Kirsty Mead joins Life from Seven …
Appointment

FDA issues final guidance on heparin testing

June 27, 2013 Manufacturing and Production, Sales and Marketing FDA, heparin

Five years after the adulterated heparin scandal that claimed the lives of dozens of people in the US alone, the …
News

ImmTAC deal for Immunocore

June 27, 2013 Research and Development, Sales and Marketing Genentech, ImmTAC, oxford biotech

Oxford-based biotech company Immunocore has signed what could be a $300 million deal with Genentech to discover and bring to …
News

Oxford BioTherapeutics hires chairman

June 27, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Oxford Biotherapeutics, morton

Biotech firm Oxford BioTherapeutics has appointed Bryan Morton to be the company’s new non-executive chairman. Morton has over 30 years’ …
Appointment

Astellas in $500m deal with Cytokinetics

June 27, 2013 Sales and Marketing Astellas, cytokinetics

Astellas Pharma could pay out $40 million over the next two years to US firm Cytokinetics as part of a …
News

Heart failure treatment given Breakthrough Status

June 27, 2013 Sales and Marketing Breakthrough Therapy Designation, Novartis, RLX03O, serelaxin

Novartis’ new treatment for heart failure has been granted Breakthrough Therapy designation status by the FDA. RLX030 (serelaxin) is for …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026